Ignite Creation Date:
2024-05-06 @ 8:17 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06326268
Status:
RECRUITING
Last Update Posted:
2024-04-22
First Post:
2024-03-11
Brief Title:
Interest of Light Therapy in Hematology - The PHOTO-TREAT Study
Sponsor:
Institut de cancérologie Strasbourg Europe
Organization:
Institut de cancérologie Strasbourg Europe
Study Overview
Official Title:
Validation of the Improvement in the Management of Chemo-induced Mucositis in Hematology Through the Contribution of Photobiomodulation - The PHOTO-TREAT Study
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PHOTO-TREAT
Brief Summary:
Chemo-induced mucositis is a common complication in patients treated for hematologic malignancies They can manifest itself as a simple local irritation with erythema and inflammation but can also progress to erosions and ulcerations of the entire oral mucosa and are also responsible for an increased risk of infection in these immunocompromised patients
The only therapies currently offered are local care and intravenous analgesics Studies in pediatric hematology show the effectiveness of prevention and low-dose laser treatment in chemo-induced mucositis both in terms of reducing the number of mucositis developed but also in terms of reducing the grade of mucositis This currently results in a recommendation for the use of photobiomodulation by international bodies such as ESMO European Society for Medical Oncology
The only therapies currently offered are local care and intravenous analgesics Studies in pediatric hematology show the effectiveness of prevention and low-dose laser treatment in chemo-induced mucositis both in terms of reducing the number of mucositis developed but also in terms of reducing the grade of mucositis This currently results in a recommendation for the use of photobiomodulation by international bodies such as ESMO European Society for Medical Oncology
Detailed Description:
During this research the investigators aim at validating the efficacy and impact of photo-biomodulation in the management of chemo-induced mucositis in hematology department of Strasbourg Cancer Institute ICANS
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2023-A02133-42 | OTHER | ID-RCB Number | None |